Navigation Links
AtheroGenics Reports ARISE Trial Results for AGI-1067

al programs in rheumatoid arthritis and asthma utilizing its proprietary vascular protectant® technology. For more information about AtheroGenics, please visit http://www.atherogenics.com.

Disclosure Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve significant risks and uncertainties, including preliminary summary statements relating to the analysis of AtheroGenics' ARISE study for AGI-1067 and preliminary summary statements relating to the potential efficacy and safety profile of AGI-1067. These and other statements contained in this press release that relate to events or developments that we expect or anticipate will occur in the future are deemed to be forward-looking statements, and can be identified by words such as "believes," "intends," "expects" and similar expressions. Such statements are subject to certain factors, risks and uncertainties that may cause actual results, events and performances to differ materially from those referred to in such statements. AtheroGenics cautions investors not to place undue reliance on the forward-looking statements contained in this release. The preliminary results discussed in this release may not be confirmed upon full analysis of the detailed results of the ARISE study and additional information relating to the safety, efficacy or tolerability of AGI-1067, may be discovered upon further analysis of trial data. In addition, our forward-looking statements are subject to a number of factors that could cause actual outcomes to differ materially from those expressed or implied in our forward-looking statements, including that the Food and Drug Administration might not allow us to conduct further studies of the efficacy of AGI-1067 for the same or new endpoints, and, to the extent approved, additional clinical trial wo
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AtheroGenics Reports ARISE Trial Results for AGI
(Date:9/18/2014)... HILL, S.C. , Sept. 18, 2014   3D ... addition of the Simbionix RobotiX Mentor™ , a new ... shown for the first time at the ERUS exhibition in ... to 19 (booth #7). Robotic-assisted minimally invasive surgery ... increased demand means the needs for training for robotic surgery ...
(Date:9/18/2014)... , Sept. 18, 2014 Veterinary biologic ... Dr. Ashraf Hanna , M.D., Ph.D., and Dr. ... of Directors. Dr. Hanna is the Vice President of ... Financial Officer for the Genentech Foundation, while Dr. McCracken ... of Business Development and Licensing for Roche Pharma. ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
Breaking Medicine Technology:3D Systems Introduces New Simbionix Robotics Training Platform 23D Systems Introduces New Simbionix Robotics Training Platform 3Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... MYRTLE BEACH, S.C., Sept. 19, 2011 Laser ... has received an FDA approval for its revolutionary laser ... treats pain through nerve tissue regeneration. ... trigeminal nerve in the face. The trigeminal nerve (the ...
... 19, 2011 Bayer HealthCare, one of the world,s ... to support the Women,s International Leadership (WIL) Program at ... that Bayer HealthCare has established as part of its ... to further develop an environment that fosters the development ...
Cached Medicine Technology:FDA Approved, Non-Invasive Laser Is A Success in Trigeminal Neuralgia Pain Treatment 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 2International House and Bayer HealthCare Partner to Prepare Women for Leadership Positions 3
(Date:9/18/2014)... 2014 Limited spots remain at Becker's ... 100 spots are still available for Becker's ASC 21st ... on October 23-25, 2014 at the Swissotel Chicago. , ... Information Officer Strategy Roundtable on November 4, 2014 at ... for Becker's Hospital Review Chief Executive Officer Strategy Roundtable ...
(Date:9/18/2014)... Angeles, CA (PRWEB) September 18, 2014 ... manufacture and refine carbon dioxide, selling it to downstream ... largest markets for carbon dioxide are food and beverage ... products, such as fruits, vegetables or pizzas. The gas ... Beverage manufacturers use the compound to carbonate soft drinks, ...
(Date:9/18/2014)... Amy Norton HealthDay Reporter , ... dose of a common antidepressant can quickly alter the way ... The findings, reported online Sept. 18 in Current ... response to widely prescribed antidepressants. Experts said the hope is ... are likely to benefit from a drug -- and which ...
(Date:9/18/2014)... Chest Physicians (CHEST) together with the Chinese Thoracic ... of CTS that CHEST World Congress 2016 will ... critical care, and sleep medicine from around the ... slated for spring 2016. , CHEST World ... hands-on simulation training, keynote addresses, presentations by leading ...
(Date:9/18/2014)... Thousands of college and high school ... fundraising impact on 127 member Children’s Miracle Network ... Dance Marathon Day will officially kick off a school ... raised by college and high school students funding vital ... Dance Marathon campus programs help provide medical equipment, treatment ...
Breaking Medicine News(10 mins):Health News:Limited Spots Remain at Becker's Upcoming ASC and Hospital Conferences 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Carbon Dioxide Production in the US Industry Market Research Report Now Available from IBISWorld 3Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 2Health News:One Dose of Antidepressant Changes Brain Connections, Study Says 3Health News:CHEST announces China as site of CHEST World Congress 2016 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2
... ShopAtHome.com, a leading Free Coupon and Cash Back ... 1, 2009 to help shoppers shop, save, and donate! ... Komen for the Cure® as part of a month-long ... http:// href="http://www.newscom.com/cgi-bin/prnh/20091001/LA85003LOGO"> www.newscom.com/cgi-bin/prnh/20091001/LA85003LOGO ) , ...
... CITY, Mo., Oct. 1 DST Systems, Inc. (NYSE: ... Company has entered into separate privately negotiated exchange agreements ... principal of the Company,s outstanding 4.125% Series A Convertible ... in aggregate principal of new 4.125% Series C Convertible ...
... recent study published in the October 2009 issue of the ... specific genetic markers identified in previous research, or SNPs, may ... in whites. The genes CHRNA3 and CHRNA5 may contribute to ... nicotine dependence. Although their presence is less frequent in African ...
... Many patients urgently admitted to hospital with cerebral infarction ... prolonged period prior to suffering their stroke, is shown ... the Sahlgrenska Academy at the University of Gothenburg and ... published in the scientific journal BMC Medicine . ...
... they get less sleep than they actually do, study finds ... longer and better than older men, even though many women ... found. , The study of 956 people, aged 59 to ... men on all of the self-reported measures, including a 13.2 ...
... Attacks New York Department of ,Hype, with New York Times Ad ... (CCF) is running a full-page ad in the New York Times ... Department of Health,s hyperbolic "Don,t drink yourself fat" PSA campaign. The Center ... News and New York Post that ask New Yorkers, ...
Cached Medicine News:Health News:ShopAtHome.com Helps Shoppers Save Money and Support Breast Cancer Research 2Health News:DST Systems, Inc. Announces Exchange Transaction Involving 4.125% Series A Convertible Senior Debentures 2Health News:Lung cancer risk increases with expression of specific genes 2Health News:Severe stress can cause stroke 2Health News:Older Women May Sleep Better Than Men 2Health News:Consumer Group Continues Million Dollar Campaign Responding to NYC Health Officials' Hyperbolic PSA Campaign 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: